Skip to main content

PnuBioVax™: next-generation vaccine for a personalised and effective immune response against Streptococcus pneumoniae.

Description du projet

Next-generation vaccine against pneumococcal disease

Appel à propositions

H2020-SMEInst-2018-2020-1
Voir d’autres projets de cet appel

Régime de financement

SME-1 - SME instrument phase 1

Coordinateur

IMMUNOBIOLOGY LIMITED
Adresse
Babraham Research Campus Building 260
CB22 3AT Cambridge
United Kingdom
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contribution de l’UE
€ 50 000